Improving genetic testing for breast and ovarian cancer in diverse women
Electronic health record (EHR)-based implementation strategies and decision support for hereditary breast and ovarian cancer (HBOC) genetic testing among multiethnic women (ELISABETH)
['FUNDING_OTHER'] · COLUMBIA UNIVERSITY HEALTH SCIENCES · NIH-11035750
This study is all about helping women, especially those from different backgrounds, get better access to genetic testing for breast and ovarian cancer, so they can understand their risk and make informed choices about their health.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | COLUMBIA UNIVERSITY HEALTH SCIENCES (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11035750 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the use of genetic testing for hereditary breast and ovarian cancer (HBOC) among women, particularly those from diverse backgrounds. It aims to identify women with genetic variants that increase their cancer risk, enabling better management strategies like increased screening and preventive surgeries. The project utilizes electronic health records to implement decision support tools for both patients and primary care providers, addressing barriers to testing and improving access to genetic counseling. By integrating family history screening into routine care, the research seeks to increase the rates of genetic testing among underrepresented populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include women, particularly those from multiethnic backgrounds, who may be at risk for hereditary breast and ovarian cancer due to family history or genetic factors.
Not a fit: Patients who do not have a family history of breast or ovarian cancer or those who are not interested in genetic testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the identification of women at high risk for breast and ovarian cancer, leading to earlier interventions and improved health outcomes.
How similar studies have performed: Previous research has shown success in increasing genetic testing rates through similar implementation strategies and decision support tools.
Where this research is happening
NEW YORK, UNITED STATES
- COLUMBIA UNIVERSITY HEALTH SCIENCES — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CREW, KATHERINE D — COLUMBIA UNIVERSITY HEALTH SCIENCES
- Study coordinator: CREW, KATHERINE D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.